"Normal" liver stiffness measure (LSM) values are higher in both lean and obese individuals: A population-based study from a developing country

Hepatology

Volumn 55, Issue 2, 2012, Pages 584-593

  Das, Kausik ^a   Sarkar, Rajib ^a   Ahmed, Sk Mahiuddin ^a   Mridha, Asit R ^a   Mukherjee, Partha S ^b   Das, Kshaunish ^a   Dhali, Gopal K ^a   Santra, Amal ^a   Chowdhury, Abhijit ^a  

^a INSTITUTE OF POST GRADUATE MEDICAL EDUCATION AND RESEARCH   (India)

^b Liver Foundation   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN;

ABDOMINAL OBESITY; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BODY MASS; CHOLESTEROL BLOOD LEVEL; CHRONIC HEPATITIS; CONTROLLED STUDY; DEVELOPING COUNTRY; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; INSULIN BLOOD LEVEL; LEAN BODY WEIGHT; LIVER BIOPSY; LIVER DISEASE; LIVER EXAMINATION; LIVER FIBROSIS; LIVER STIFFNESS MEASURE; MAJOR CLINICAL STUDY; MALE; NONALCOHOLIC FATTY LIVER; OBESITY; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; STEATOSIS; SUBCUTANEOUS FAT;

ADULT; CASE-CONTROL STUDIES; DEVELOPING COUNTRIES; ELASTICITY; ELASTICITY IMAGING TECHNIQUES; FEMALE; HUMANS; INDIA; LIVER; LIVER CIRRHOSIS; LIVER DISEASES; MALE; MIDDLE AGED; OBESITY; REFERENCE VALUES; ROC CURVE;

EID: 84856380963     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.24694     Document Type: Article

References (47)

1. Castera L, Forns X, Alberti A. Non-invasive evaluation of liver fibrosis by transient elastography. J Hepatol 2008; 48: 835-847.
2. Vergniol J, Foucher J, Terrebonne E, Bernard PH, Bail BL, Merrouche W, et al. Noninvasive tests for fibrosis and liver stiffness predict 5-year outcomes of patients with chronic hepatitis C. Gastroenterology 2011; 140: 1970-1979.
3. Kumar M, Sarin SK, Hissar S, Pande C, Sakhuja P, Sharma BC, et al. Virologic and histologic features of chronic hepatitis B virus-infected asymptomatic patients with persistently normal ALT. Gastroenterology 2008; 134: 1376-1384.
4. Bedossa P, Poynard T; The French METAVIR Cooperative Study Group. An algorithm for grading activity in chronic hepatitis C. HEPATOLOGY 1996; 24: 289-293.
5. Friedrich-Rust M, Ong MF, Martens S, Sarrazin C, Bojunga J, Zeuzem S, et al. Performance of transient elastography for the staging of liver fibrosis: a meta-analysis. Gastroenterology 2008; 134: 960-974.
6. Roulot D, Costes JL, Buyck JF, Warzocha U, Gambier N, Czernichow S, et al. Transient elastography as a screening tool for liver fibrosis and cirrhosis in a community-based population aged over 45 years. Gut 2011; 60: 977-984.
7. Castéra L, Foucher J, Bernard PH, Carvalho F, Allaix D, Merrouche W, et al. Pitfalls of liver stiffness measurement: a 5-year prospective study of 13, 369 examinations. HEPATOLOGY 2010; 51: 828-835.
8. Poynard T, Ingiliz P, Elkrief L, Munteanu M, Lebray P, Morra R, et al. Concordance in a world without a gold standard: a new non-invasive methodology for improving accuracy of fibrosis markers. PLoS One 2008; 3: e3857.
9. Georges PC, Hui JJ, Gombos Z, McCormick ME, Wang AY, Uemura M, et al. Increased stiffness of the rat liver precedes matrix deposition: implications for fibrosis. Am J Physiol Gastrointest Liver Physiol 2007; 293: G1147-G1154.
10. Roulot D, Czernichow S, Le Clésiau H, Costes JL, Vergnaud AC, Beaugrand M. Liver stiffness values in apparently healthy subjects: influence of gender and metabolic syndrome. J Hepatol 2008; 48: 606-613.
11. Corpechot C, El Naggar A, Poupon R. Gender and liver: is the liver stiffness weaker in weaker sex? HEPATOLOGY 2006; 44: 513-514.
12. Das K, Das K, Mukherjee PS, Ghosh A, Ghosh S, Mridha AR, et al. Nonobese population in a developing country has a high prevalence of nonalcoholic fatty liver and significant liver disease. HEPATOLOGY 2010; 51: 1593-1602.
13. WHO expert consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 2004; 363: 157-163.
14. Misra A, Khurana L. Obesity and the metabolic syndrome in developing countries. J Clin Endocrinol Metab 2008; 93: S9-S30.
15. Chowdhury A, Santra A, Chaudhuri S, Dhali GK, Chaudhuri S, Maity SG, et al. Hepatitis C virus infection in the general population: a community-based study in West Bengal, India. HEPATOLOGY 2003; 37: 802-809.
16. Chowdhury A, Santra A, Chakravorty R, Banerji A, Pal S, Dhali GK, et al. Community-based epidemiology of hepatitis B virus infection in West Bengal, India: prevalence of hepatitis B e antigen-negative infection and associated viral variants. J Gastroenterol Hepatol 2005; 20: 1712-1720.
17. Yajima Y, Ohta K, Narui T, Abe R, Suzuki H, Ohtsuki M. Ultrasonographical diagnosis of fatty liver: significance of the liver-kidney contrast. Tohoku J Exp Med 1983; 139: 43-50.
18. Alberti KGMM, Zimmet P, Shaw J, for the IDF Epidemiology Task Force Consensus Group. The metabolic syndrome-a new worldwide definition. Lancet 2005; 366: 1059-1062.
19. Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and B-cell function from fasting glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419.
20. Schuppan D, Afdhal NH. Liver cirrhosis. Lancet 2008; 371: 838-851.
21. Farrell GC, Chitturi S, Lau GKK, Sollano JD, for the Asia-Pacific Working Party on NAFLD. Guidelines for the assessment and management of non-alcoholic fatty liver disease in the Asia-Pacific region: executive summary. J Gastroenterol Hepatol 2007; 22: 775-777.
22. Ghany MG, Strader DB, Thomas DL, Seef LB. AASLD Practice Guidelines. Diagnosis, management, and treatment of hepatitis C: an update. Hepatology 2009; 49: 1335-1374.
23. Lok AS, McMahon BJ. Chronic hepatitis B. Hepatology 2007; 45: 507-539.
24. Alvarez F, Berg PA, Bianchi FB, Bianchi L, Burroughs AK, Cancado EL, et al. International Autoimmune Hepatitis Group report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 1999; 31: 929-938.
25. Menghini G. One-second needle biopsy of the liver. Gastroenterology 1958; 35: 190-199.
26. Kleiner DE, Brunt EM, Natta MV, Behling C, Contos MJ, Cummings OW, et al. for the Nonalcoholic Steatohepatitis Clinical Research Network. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. HEPATOLOGY 2005; 41: 1313-1321.
27. Green R, Flamm S. AGA technical review on the evaluation of liver chemistry tests. Gastroenterology 2002; 123: 1367-1384.
28. Williams R. Global challenges in liver disease. Hepatology 2006; 44: 521-526.
29. Quigley MA. Shifting burden of disease-epidemiological transition in India. Int J Epidemiol 2006; 35: 1530-1531.
30. Food and Agriculture Organization of the United Nations. The double burden of malnutrition: case studies from six developing countries. FAO Food Nutr Pap 2006; 84: 1-334.
31. Sirli R, Sporea I, Tudora A, Deleanu A, Popescu A. Transient elastographic evaluation of subjects without known hepatic pathology: does age change the liver stiffness? J Gastrointest Liver Dis 2009; 18: 57-60.
32. Orescanin M, Qayyum MA, Toohey KS, Insana MF. Dispersion and shear modulus measurements of porcine liver. Ultrason Imaging 2010; 32: 255-266.
33. Roan E. The effect of Glisson's capsule on the superficial elasticity measurements of the liver. J Biomech Eng 2010; 132: 104-105.
34. Vizzutti F, Arena U, Romanelli RG, Rega L, Foschi M, Colagrande S, et al. Liver stiffness measurement predicts severe portal hypertension in patients with HCV-related cirrhosis. Hepatology 2007; 45: 1290-1297.
35. Millonig G, Friedrich S, Adolf S, Fonouni H, Golriz M, Mehrabi A, et al. Liver stiffness is directly influenced by central venous pressure. J Hepatol 2010; 52: 206-210.
36. Millonig G, Reimann FM, Friedrich S, Fonouni H, Mehrabi A, Buchler MW, et al. Extrahepatic cholestasis increases liver stiffness (FibroScan) regardless of fibrosis. HEPATOLOGY 2008; 48: 1718-1723.
37. Sagir A, Erhardt A, Schmitt M, Haussinger D. Transient elastography is unreliable for detection of cirrhosis in patients with acute liver damage. Hepatology 2008; 47: 592-595.
38. Yoneda M, Fujita K, Inamori M, Nakajima A, Tamano M, Hiraishi H. Transient elastography in patients with non-alcoholic fatty liver disease (NAFLD). Gut 2007; 56: 1330-1331.
39. Gaia S, Carenzi S, Barilli AL, Bugianesi E, Smedile A, Brunello F et al. Reliability of transient elastography for the detection of fibrosis in non-alcoholic fatty liver disease and chronic viral hepatitis. J Hepatol 2011; 54: 64-71.
40. Jacqueminet S, Lebray P, Morra R, Munteanu M, Devers L, Messous D, et al. Screening for liver fibrosis by using a noninvasive biomarker in patients with diabetes. Clin Gastroenterol Hepatol 2008; 6: 828-831.
41. Poynard T, Lebray P, Ingiliz P, Varaut A, Varsat B, Ngo Y, et al. Prevalence of liver fibrosis and risk factors in a general population using non-invasive biomarkers (FibroTest). BMC Gastroenterol 2010; 10: 40.
42. Poynard T, Ngo Y, Munteanu M, Thabut D, Massard J, Moussalli J, et al. Biomarkers of liver injury for hepatitis clinical trials: a meta-analysis of longitudinal studies. Antivir Ther 2010; 15: 617-631.
43. Tsochatzis EA, Gurusamy KS, Ntaoula S, Cholongitas E, Davidson BR, Burroughs AK. Elastography for the diagnosis of severity of fibrosis in chronic liver disease: a meta-analysis of diagnostic accuracy. J Hepatol 2011; 54: 650-659.
44. Bedossa P, Dargère D, Paradis V. Sampling variability of liver fibrosis in chronic hepatitis C. HEPATOLOGY 2003; 38: 1449-1457.
45. Poynard T, Benhamou Y, Thabut D, Ratziu V. Liver biopsy: the best standard when everything else fails. J Hepatol 2009; 50: 1267-1268.
46. Rockey DC, Boyles JK, Gabbiani G, Friedman SL. Rat hepatic lipocytes express smooth muscle actin upon activation in vivo and in culture. J Submicrosc Cytol Pathol 1992; 24: 193-203.
47. Rockey DC, Housset CN, Friedman SL. Activation-dependent contractility of rat hepatic lipocytes in culture and in vivo. J Clin Invest 1993; 92: 1795-1804.